A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine
International Journal of Molecular Sciences · 11.01.2024 · 25 (2) · 913
DOI: 10.3390/ijms25020913 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.01.2024. Verfasst von Georgia Michailidou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Polymer and Colors Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Chitosan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Deferoxamine (DFO) is a water-soluble iron chelator used pharmacologically for the management of patients with transfusional iron overload. However, DFO is not cell-permeable and has a short plasma half-life, which necessitates lengthy parenteral administration with an infusion pump. We previously reported the synthesis of chitosan (CS) nanoparticles for sustained slow release of DFO. In the present study, we developed solid dispersions and nanoparticles of a carboxymethyl water-soluble chitosan derivative (CMCS) for improved DFO encapsulation and release. CS dispersions and nanoparticles with DFO have been prepared by ironical gelation using sodium triphosphate (TPP) and were examined for comparison purposes. The successful presence of DFO in CMCS polymeric dispersions and nanoparticles was confirmed through FTIR measurements. Furthermore, the formation of CMCS nanoparticles led to inclusion of DFO in an amorphous state, while dispersion of DFO in the polymeric matrix led to a decrease in its crystallinity according to X-ray diffraction (XRD) and differential scanning calorimetry (DSC) results. An in vitro release assay indicated sustained release of DFO from CS and CMCS nanoparticles over 48 h and 24 h, respectively. Application of CMCS-DFO dispersions to murine RAW 264.7 macrophages or human HeLa cervical carcinoma cells triggered cellular responses to iron deficiency. These were exemplified in the induction of the mRNA encoding transferrin receptor 1, the major iron uptake protein, and the suppression of ferritin, the iron storage protein. Our data indicate that CMCS-DFO nanoparticles release bioactive DFO that causes effective iron chelation in cultured cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Polymer and Colors Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
- Department of Medicine, McGill University, Montreal, QC H3T 1E2, Canada.
- Lady Davis Institute for Medical Research, Montreal, QC H3T 1E2, Canada.
ORCID-Profile: Georgia Michailidou, Alexandra Zamboulis, Kostas Pantopoulos, Dimitrios N Bikiaris
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Michailidou, G., Li, Y., Zamboulis, A., Karlioti, G., Meimaroglou, D., Pantopoulos, K., & Bikiaris, D. N. (2024). A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine. International Journal of Molecular Sciences, 25(2), 913. https://doi.org/10.3390/ijms25020913
Vancouver
Michailidou G, Li Y, Zamboulis A, Karlioti G, Meimaroglou D, Pantopoulos K, et al. A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine. International Journal of Molecular Sciences. 2024;25(2):913. doi:10.3390/ijms25020913
BibTeX
@article{Michailidou2024,
author = {Michailidou, Georgia and Li, Yupeng and Zamboulis, Alexandra and Karlioti, Georgia and Meimaroglou, Despoina and Pantopoulos, Kostas and Bikiaris, Dimitrios N},
title = {A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {2},
pages = {913},
doi = {10.3390/ijms25020913}
}
EUVIMED